A patent workflow is five stages and about twenty years, and most of what goes wrong happens between stages rather than inside them.

Capture, triage, decide, prosecute, renew.

Each stage is usually handled competently. The disclosure gets written, counsel drafts well, the examiner is answered.

What fails is the handoff — a disclosure nobody picks up, a continuation window nobody owns, a fee reminder that reaches a distribution list.

Why handoffs fail

Reason Detail
No named owner The root cause
Ambiguous trigger Nobody knows when to act
No escalation Silence goes unnoticed
Reminder to a group Diffused responsibility

The short version

Name an owner for every handoff. That single practice prevents most losses.

The five stages

Stage Owner Typical duration
1. Capture Inventors Ongoing
2. Triage Commercial + counsel Weeks, ideally
3. Filing decision Whoever holds budget Days
4. Prosecution Counsel 2–4 years
5. Renewal loop Portfolio owner Up to 20 years

Stage five is the longest and the least owned. It recurs three times per US patent and annually per foreign member.

Handoff owners at a glance

Transition Owner
Inventor → triage Named triager
Triage → filing Budget holder
Allowance → continuation Named, diarised
Grant → docket Automatic
Docket → decision Named portfolio owner

Stage 1: capture

Trigger Quality
A non-obvious solution to a real problem Correct
Before any external disclosure Critical
Project milestone Catches inventions late
Annual review Far too late
Someone remembers Unreliable

Milestone-triggered capture catches inventions after trade shows and customer demonstrations, by which point foreign rights may already be forfeited.

Train engineers on what triggers a disclosure and on what constitutes public disclosure — trade shows, conference papers, crowdfunding pages and offers for sale all count. See invention disclosure.

Speed matters more than sophistication

Measure Target
Disclosure to first response Days
Disclosure to decision Weeks
Decision communicated Always
Reasons given for a no Teaches the next one

Stage 2: triage

Step Question Cost
1 Is it commercially relevant? Free
2 Free prior art search Free
3 Patentable? Counsel time
4 Patent, publish, or keep secret? Strategy
5 Where to file Markets and manufacturing

Most disclosures should not become applications. A good process says no in weeks.

Slow triage costs foreign rights, because launches happen on their own schedule while a disclosure sits unreviewed.

Step four is a real fork. Filing forecloses trade secret permanently once the application publishes at eighteen months.

Stage 3: the filing decision

Input Detail
Prior art position From the search
Commercial relevance Does anyone practise this?
Budget $8,000–$20,000 to grant
Provisional or non-provisional Defers cost 12 months
Jurisdictions Where you sell and where competitors manufacture
Any disclosure already made Sets the deadlines

A provisional defers the main spend by twelve months without consuming term, which is why it suits inventions still being tested.

The twelve-month deadline is unextendable and it governs foreign filing too. See how to file a patent.

Stage 4: prosecution

Event Timing Owner
Filing receipt Weeks Counsel
Publication 18 months from priority Automatic
First office action 19.9 months average, FY2024 Counsel
Response 3 months, extendable Counsel + inventors
Continuation decision At notice of allowance Frequently unowned
Issue fee 3 months, no extension Counsel
Disposal 26.3 months average, FY2024

The continuation decision is the handoff that fails most. Counsel reports an allowance, which reads as good news, and the window closes when the patent issues.

Give it an explicit owner and a diary entry triggered by the notice of allowance, not by the issue fee. See continuation patent application.

The loop never ends until the patent does

Year after grant Event
3.5 First decision
7.5 Second decision
11.5 Third decision, largest fee
Annually, abroad Per country
Term end Public domain

Stage 5: the renewal loop

Fee Due after grant Large Small Micro
First 3.5 years $2,150 $860 $430
Second 7.5 years $4,040 $1,616 $808
Third 11.5 years $8,280 $3,312 $1,656
Total $14,470 $5,788 $2,894

Four options at every window, and two happen by default.

Option Requires action? Ends the fee? Pays you?
Pay No — the default No No
Sell Yes, months ahead Yes Yes
License Yes No Yes, ongoing
Lapse No — the default Yes No
Ipiry Patent Survival Curve v1.0 Rate
Survive the 3.5-year fee (2022 cohort) 85.8%
Survive the 7.5-year fee (2018 cohort) 64.6%
Reach full term (2014 cohort) 41.4%
Abandoned before full term 58.6%

Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.

Automating the reminder is right; automating the decision is not. Payment by default keeps patents nobody would consciously renew.

Where the handoffs break

Handoff Failure Fix
Inventor → triage Disclosure sits unread Named triager, SLA
Triage → filing Decision never made Explicit yes or no
Filing → prosecution Inventor unavailable for responses Named technical contact
Allowance → continuation Nobody owns it Diary entry on allowance
Grant → docket Matter never docketed Automatic on issue
Docket → decision Reminder to a distribution list Named owner
Decision → sale Started too late to sell 12-month lookahead

Every row is a person, not a system. Software surfaces the deadline; it cannot own the transition.

Reviewing the workflow itself

Ask annually Detail
Did anything lapse by accident? The sharpest measure
How long did triage take? Weeks or months
Were continuation decisions made? Or missed
Does every handoff have an owner? The root question

Roles across the workflow

Role Owns
Inventors Disclosure quality, alternatives, technical detail
Commercial Relevance, budget, renewal decisions
Counsel Drafting, prosecution, legal judgement
Docketing Deadlines and reminders
One named person per matter The handoffs

The last row is what most organisations lack, and it is where assets are lost.

Foreign filings add decision points

Point Timing
Paris Convention filing or PCT 12 months from priority
PCT national phase entry ~30 months from priority
European validation Short window after grant
Annuities Annual, per country

A four-country family generates roughly twenty deadlines a year, against three US fee windows across a patent's life. See patent annuity fees by country.

Worked example: two workflows

Organisation A Organisation B
Disclosure trigger Project milestone On solving a problem
Triage time 4 months 3 weeks
Prior art search After counsel review First, free
Continuation owner None named Named, diarised
Fee reminders to Distribution list Named owner
Annual portfolio review No Q1, 18-month lookahead

Outcomes over three years

Organisation A Organisation B
Foreign rights lost to prior disclosure 2 inventions 0
Families closed at allowance 4 0
Patents lapsed by accident 1 0
Patents released deliberately 0 6, two sold first
Spend on applications that failed §102 Higher Lower

Organisation A had no bad stages. Counsel was competent, engineers disclosed, deadlines were calculated.

Every loss came from a handoff nobody owned.

Organisation B released more patents deliberately, which is the process working rather than failing.

Tooling at each stage

Stage Minimum At volume
Capture A form Disclosure software
Triage A meeting and a spreadsheet Workflow tool
Prosecution Counsel's system Shared visibility
Renewal A calendar with both dates Docketing software or a service
Portfolio review A spreadsheet Portfolio tool

The discipline matters more than the tool at every stage. A calendar owned by a named person outperforms software routed to a distribution list.

Measuring whether it works

Measure Good
Disclosure to triage decision Weeks, not months
Share of disclosures reaching a decision Near 100%
Deadlines actioned before the final month High
Lapses that were decisions, not accidents All of them
Sales started 12 months before a deadline Some
Entity status rechecked at each payment Always

"Lapses that were decisions" is the sharpest single measure. Releasing patents is normal; losing them is not.

What never gets automated

Task Why
The renewal decision Commercial judgement
Entity status determination Depends on your circumstances
Whether to respond or abandon Legal judgement
Whether to file a continuation Strategic
Verification against office records Minutes, catches everything

Entity status is the trap. Growth past 500 employees or a licence to a large company ends small entity eligibility, and paying at the wrong rate can render a patent unenforceable. See small entity status.

Patent workflow: the checklist

  1. Name an owner for every handoff, not just every stage.
  2. Trigger disclosure on solving a problem, not on a project milestone.
  3. Run the free prior art search during triage, before counsel time.
  4. Decide patent, publish or secret before filing forecloses the last two.
  5. Triage in weeks. Slow review costs foreign rights.
  6. Diarise the continuation decision on notice of allowance.
  7. Route fee reminders to a named person, never a distribution list.
  8. Automate reminders, not decisions.
  9. Run an annual review with eighteen months of lookahead, so selling stays possible.
  10. Measure lapses that were decisions. Releasing is fine; losing is not.